drugset

drugset / Trial / NCT05566743

A Study Evaluating Maintenance Therapy After First Line Chemotherapy in Metastatic Cancer Pancreas

NCT05566743 ↗

Phase 2 Unknown 40 enrolled Menoufia University

RandomizedParallel-groupSingle-blindOther

Summary

A randomized phase II study evaluating maintenance therapy after first line induction chemotherapy in metastatic cancer pancreas.

Timeline

Start: 2022-09-11
Primary completion: 2023-09-11
Completion: 2024-09-11

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Capecitabine	Small molecule	—	—

Indications